Tag Archives: bacterial infections

Basilea Pharmaceutica Ltd secures non-dilutive refinancing from funds managed by Athyrium Capital Management, LP for its outstanding 2022 convertible bonds

Ad hoc announcement pursuant to Art. 53 LR (PRESS RELEASE) BASEL/ ALLSCHWIL, 7-Sep-2022 — /EuropaWire/ — Basilea Pharmaceutica Ltd (SWX: BSLN), a commercial stage biopharmaceutical company, has announced the company has secured non-dilutive refinancing in the amount of CHF 75 … Read the full press release

Basilea announced improved operating results in its H1-2013 financials

Continued improvement in financial performance Cash and short-term investments of CHF 262.8 million Guidance on isavuconazole phase 3 topline data and ceftobiprole regulatory decision in Europe maintained for H2 2013 Significant agreement with BARDA of up to USD 89 million … Read the full press release